Cargando…
Why the MDGs need good governance in pharmaceutical systems to promote global health
BACKGROUND: Corruption in the health sector can hurt health outcomes. Improving good governance can in turn help prevent health-related corruption. We understand good governance as having the following characteristics: it is consensus-oriented, accountable, transparent, responsive, equitable and inc...
Autores principales: | Kohler, Jillian Clare, Mackey, Tim Ken, Ovtcharenko, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909282/ https://www.ncbi.nlm.nih.gov/pubmed/24447600 http://dx.doi.org/10.1186/1471-2458-14-63 |
Ejemplares similares
-
Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
por: Mackey, Tim K, et al.
Publicado: (2013) -
The Ebola Outbreak: Catalyzing a “Shift” in Global Health Governance?
por: Mackey, Tim K.
Publicado: (2016) -
Combating healthcare corruption and fraud with improved global health governance
por: Mackey, Tim K, et al.
Publicado: (2012) -
Africa's health: could the private sector accelerate the progress towards health MDGs?
por: Sambo, Luis G, et al.
Publicado: (2011) -
Vaccine nationalism will persist: global public goods need effective engagement of global citizens
por: Peacock, Stuart J.
Publicado: (2022)